Cargando…
Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome
Post-treatment Lyme disease syndrome (PTLDS) is a pain disorder for which there remains no gold standard treatment option. Here, we report a case of PTLDS in a female patient whose pain was refractory to treatment options such as radiofrequency ablation, vitamin infusion therapy, opioid analgesics,...
Autores principales: | Hanna, Ashraf F, Abraham, Bishoy, Hanna, Andrew, Smith, Adam J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571854/ https://www.ncbi.nlm.nih.gov/pubmed/28860873 http://dx.doi.org/10.2147/IMCRJ.S137975 |
Ejemplares similares
-
Effects of Intravenous Ketamine Infusions in a Neuropathic Pain Patient with Lichen Sclerosus et Atrophicus
por: Hanna, Ashraf F., et al.
Publicado: (2016) -
Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment Lyme Disease Syndrome
por: Novak, Cheryl, et al.
Publicado: (2017) -
Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options
por: Talbot, Norris C, et al.
Publicado: (2023) -
The Persistent Lyme Disease: “True Chronic Lyme Disease” rather than “Post-treatment Lyme Disease Syndrome”
por: Lacout, Alexis, et al.
Publicado: (2018) -
Autoantibodies in post-treatment Lyme disease syndrome
por: Alaedini, Armin, et al.
Publicado: (2022)